Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2007
12/25/2007US7312344 Dimeric isoflavones
12/25/2007US7312342 Process for the preparation of (3-cyano-1h-indol-7-yl) (4-(4-fluorophenethyl) piperazin-1-yl)-methanone and salts thereof
12/25/2007US7312338 use treating peroxysome proliferator-activated receptor gamma (PPAR gamma ) mediated diseases and conditions such as diabetes, insulin resistance; e.g. 2-(1,3-benzoxazol-2-ylamino)-3-(4-(2,3-dihydro-1,4-benzodioxin-6-ylmethoxy)phenyl)propionic acid
12/25/2007US7312336 Ligands for the delta opiod receptor; novel compounds which possess a piperidine ring with an exocyclic double bond do not show significant convulsive effects when administered systemically
12/25/2007US7312333 N-heterocyclic hydroxyethylamine compounds; human immunodeficiency virus (HIV) protease
12/25/2007US7312330 Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
12/25/2007US7312328 Antiinflammatory agents; autoimmune disease; rheumatic diseases; multiple sclerosis; respiratory system disorders
12/25/2007US7312325 RNA aptamers and methods for identifying the same
12/25/2007US7312317 P2Y4 antibodies
12/25/2007US7312266 Mercaptan-containing aliphatic diester utilized for halogen-containing polymers, especially poly(vinyl chloride);
12/25/2007US7312250 Fluorine-substituted alkyl phenol compounds and their uses
12/25/2007US7312249 Vitamin D analogues
12/25/2007US7312248 Parasiticides; nematocides; crop protection
12/25/2007US7312247 Histone deacetylase inhibitors
12/25/2007US7312245 controlling harmful drug resistant fungi at lower concentrations; safe for crops; rice blast
12/25/2007US7312244 For therapy of cancer, as antitumor agent
12/25/2007US7312243 Materials and methods for treatment of gastrointestinal disorders
12/25/2007US7312242 Use of parthenolide derivatives as antileukemic and cytotoxic agents
12/25/2007US7312241 Diphenylethylene compounds and uses thereof
12/25/2007US7312240 Conformationally constrained paclitaxel analogs and their use as anticancer and anti-Alzheimers agents
12/25/2007US7312239 Medicament for prevention and/or therapy of arterial wall disorder
12/25/2007US7312238 Nonsedating α-2 agonists
12/25/2007US7312237 Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolilferative diseases
12/25/2007US7312236 Inhibiting dural protein extravasation; migraines
12/25/2007US7312235 Anticoagulants
12/25/2007US7312234 Chemokine receptor binding heterocyclic compounds
12/25/2007US7312233 4-(2,2-dichlorocyclopropyl)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's disease, Alzheimer's disease, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
12/25/2007US7312232 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/25/2007US7312231 Quaternization of compound for treatment of urogenital disorders, respiratory system disorders or gastrointestinal disorders
12/25/2007US7312230 Carboxylic acid derivatives as IP antagonists
12/25/2007US7312229 21-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators
12/25/2007US7312228 Cytotoxic indeno and isoindoloisoquinolones
12/25/2007US7312227 Autoimmune diseases; Alzheimer's disease; Parkinson's disease; bone disorders; liver disorders; rheumatic disease; amythrophiic lateral sclerosis
12/25/2007US7312226 1-Benzo[1.3]dioxol-5-yl methyl-3-[2-(6,7-dimethoxy-quinazolin-4ylamino)-pyrimidin-5yl]-thiourea (14); anticarcinogenic, antitumor, antdiabetic, antiproliferative agent
12/25/2007US7312225 inhibit cyclin-dependent kinases and VEGF-receptor tyrosine kinases
12/25/2007US7312224 Pyrimidine derivatives
12/25/2007US7312223 8-Amino-7-phenylmethyl-1-ethyl-3,7-dihydro-3-(2-hydroxyethyl)-purine-2,6-dione derivatives; urogenital, respiratory system, kidney, cardiovascular, autoimmune or brain disorders; angina pectoris, hypertension, restenosis; anticarcinogenic, hypoglycemic, antiischemic, and hypotensive agents; diabetes
12/25/2007US7312222 Heterocyclic piperidines as modulators of chemokine receptor activity
12/25/2007US7312221 Therapeutic treatment of endotoxic shock with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating psoriasis, arthritis, osteoarthritis, glomerulonephriti, autoimmune disorder include diabetes, asthma, or multiple sclerosis
12/25/2007US7312220 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/25/2007US7312219 Antidiabetic agents
12/25/2007US7312218 For use as anticoagulant agents for therapy of thromboembolic disorders; 6-chloro-naphthalene-2-sulfonic acid [1-(1-cyclopentyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide; )-2-methyl-benzothiazole-6-sulfonic acid [1-(1-isopropyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide
12/25/2007US7312217 Aminopterin dosage forms and methods for inflammatory disorders
12/25/2007US7312216 N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-piperazin-1-ylmethyl-benzamide methanesulfonate; antiproliferative agent
12/25/2007US7312215 Anticancer agents
12/25/2007US7312214 Anticoagulants; atherosclerosis; strokes; thrombosis; cardiovascular disorders
12/25/2007US7312213 Substituted benzo[e][1,4]oxazino[3,2-g]isoindole compounds
12/25/2007US7312212 Bactericides for infrections in man
12/25/2007US7312211 Cathepsin S, K, F, L and B reversible inhibitory amidino and guanidino peptidyl compounds useful for treating autoimmune diseases, rheumatoid arthritis, multiple sclerosis, asthma and osteoporosis
12/25/2007US7312210 7-Methoxy-8-{3-[4-(2-oxo-2H-4-chromenyl)piperazino]propyl}-oxy-(11aS)-1,2,3,11a-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one(5a); antitumor, anticarcinogenic agents;
12/25/2007US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives
12/25/2007US7312208 Quaternary ammonium compounds
12/25/2007US7312207 Topical steroid cream formulations
12/25/2007US7312206 Sterol derivatives, liposomes comprising sterol derivatives and method for loading liposomes with active substances
12/25/2007US7312205 Methods and compositions for inhibiting tumor growth
12/25/2007US7312203 1H-8-oxa-1-aza-dibenzo[e,h]azulene; dual inhibitors of tumour necrosis factor(alpha) and interleukin 1; antiinflammatory, analgesics
12/25/2007US7312201 Tetracyclic bicyclolides
12/25/2007US7312200 9-ketospinosyn derivatives
12/25/2007US7312194 Delivery systems
12/25/2007US7312078 Methods of controlling proliferation and differentiation of stem and progenitor cells
12/25/2007US7311927 Antiseptic solutions containing silver chelated with polypectate and EDTA
12/25/2007US7311925 Applying to surface a pharmacologically acceptable composition comprising isoleucine in a microbial blocking quantity
12/25/2007US7311924 Compositions and methods for treating cancer
12/25/2007US7311921 Effective against FIVDix, FIVUK8, FIVBang, FIVAom1, FIVAom2, FIVPet, and FIVShi.
12/25/2007US7311917 Membrane proteins; fusion proteins; vaccines; kits
12/25/2007US7311901 Hydrophilic comonomers of alkylene glycol, vinyl alcohols, vinylpyrrolidone, and/or acrylamide; hydrophobic comonoomer of lactic acid, glycolic acid, 6-hydroxycaproic acid, and/or dioxan-2-one substituted with tocopherol or cholesterol; stable micelles for delivery of anticarcinogenic agents
12/25/2007US7311894 The invention relates to propellant gas formulations containing suspensions of the crystalline monohydrate of (1 7-((hydroxydi-2-thienylacetyl)oxy)-9, 9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.02,4)nonane-bromide.
12/24/2007CA2602460A1 Improving the energy status of an individual by enhanced usage of an endogenous fuel source
12/23/2007CA2552996A1 Window period vaccine small interference rnas vaccines for the prevention and treatment of viral respiratory infectious diseases
12/21/2007WO2007147160A2 Aprepitant compositions
12/21/2007WO2007147134A2 Treating obesity with muscarinic receptor m1 antagonists
12/21/2007WO2007147133A1 Stabilized tetracycline compositions
12/21/2007WO2007147128A2 Non-toxic anti-cancer drug combining ascorbate, magnesium and a naphthoquinone
12/21/2007WO2007147125A2 Tetracycline package formulations
12/21/2007WO2007147123A1 Treating psychological conditions using muscarinic receptor m1 antagonists
12/21/2007WO2007147117A2 Methods of reducing or eliminating salmonella in reptiles and/or their eggs
12/21/2007WO2007147109A2 Novel compounds
12/21/2007WO2007147104A2 Novel compounds
12/21/2007WO2007147103A2 Novel compounds
12/21/2007WO2007147085A2 Treatment of wound using aganocides and negative pressure
12/21/2007WO2007147043A2 Pharmaceutical formulations for iontophoretic tetracycline antibiotic delivery
12/21/2007WO2007147001A2 Lyophilized formulations of anti-egfr antibodies
12/21/2007WO2007146983A2 Compositions comprising tegaserod alone or in combination with a proton pump inhibitor for treating or preventing gastric injury
12/21/2007WO2007146981A2 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha
12/21/2007WO2007146977A1 2-anilino-4-aminoalkyleneaminopyrimidines
12/21/2007WO2007146965A2 Compounds for the treatment of periodontal disease
12/21/2007WO2007146920A2 Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals
12/21/2007WO2007146914A1 Ghrelin modulating compounds
12/21/2007WO2007146900A2 Antihypertensive therapy method
12/21/2007WO2007146890A2 Preparation and utility of substituted pyrazole compounds with cannabinoid receptor activity
12/21/2007WO2007146870A1 Cyclic substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity
12/21/2007WO2007146869A1 Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity
12/21/2007WO2007146867A2 Aliphatic pyrazinoylguanidine sodium channel blockers with beta agonist activity
12/21/2007WO2007146835A2 Indenoisoquinoline-releasable polymer conjugates
12/21/2007WO2007146831A2 Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide
12/21/2007WO2007146823A2 Carbohydrate derivatives of heptanoic acids
12/21/2007WO2007146816A2 Tamanu oil products
12/21/2007WO2007146805A2 Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailabilty
12/21/2007WO2007146796A2 Antiproliferative compounds, compositions and methods of use
12/21/2007WO2007146795A2 Pharmaceutical formulation for parenteral administration
1 ... 3448 3449 3450 3451 3452 3453 3454 3455 3456 3457 3458 3459 3460 3461 3462 3463 3464 3465 3466 3467 3468 ... 7860